drugset / Trial / NCT04026464

Addition of Acetaminophen in Standard PDA Management

NCT04026464

Phase 2 Withdrawn University of Florida
RandomizedParallel-groupSingle-blindTreatment

Summary

Patent ductus arteriosus is a common morbidity in preterm infants and management of PDA varies among neonatologist. The investigators are conducting a randomized controlled trial to determine the rates of initial patent ductus arteriosus (PDA) closure after completion of a first treatment course.

Timeline

Start
2021-04
Primary completion
2021-05-12
Completion
2021-05-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 15 mg/kg Oral
Comparator Ibuprofen Small molecule 5 mg/kg Intravenous